 |
|
|
| |
All-oral Dual Combination of Daclatasvir plus Asunaprevir Compared with Telaprevir plus Peginterferon Alfa/Ribavirin in Treatment-naive Japanese Patients Chronically infected with HCV Genotype 1b: The AI447031 Study
|
| |
| |
Reported by Jules Levin
APASL 2015
24th Conference of the Asian Pacific Association for the Study of Liver
Istanbul, Turkey, March 12-15, 2015
Yoshiyasu Karino,1 Fumitaka Suzuki,2 Yoshiyuki Suzuki,2 Joji Toyota,1 Kazuaki Chayama,3 Yoshiiku Kawakami,3 Shigetoshi Fujiyama,4 Takayoshi Ito,5 Yoshito Itoh,6 Etsuko Tamura,7 Tomoko Ueki,7 Hiroki Ishikawa,7 Misti Linaberry,8 Eric Hughes,8 Hiromitsu Kumada2
1Sapporo-Kosei General Hospital, Sapporo, Japan; 2Toranomon Hospital, Tokyo, Japan; 3Hiroshima University, Hiroshima, Japan; 4Kumamoto Shinto General Hospital, Kumamoto, Japan; 5Showa University Koto Toyosu Hospital, Tokyo, Japan; 6Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan; 7Bristol-Myers KK, Tokyo, Japan; 8Bristol Myers Squibb Research and Development, Princeton, NJ, USA
|
| |
|
|
|
|
|
